Metoprolol Retard Stada

Metoprolol Tartrate, the active ingredient in Metoprolol Retard Stada, is a beta‑blocker presented as an oral tablet for oral use. It is employed to lower blood pressure, relieve angina, and improve outcomes after myocardial infarction and in chronic heart failure. GNH USA supplies Metoprolol Retard Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Retard Stada is a selective β1‑blocker used in several cardiovascular conditions. Hypertension: lowers systolic and diastolic pressure by reducing heart rate and cardiac output. Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. Post‑myocardial infarction: improves survival by limiting arrhythmias and remodeling. Chronic heart failure: enhances ventricular function and reduces hospitalization risk. Cardiac arrhythmias: controls ventricular rate in atrial fibrillation and other tachyarrhythmias.

Metoprolol Retard Stada may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Cold extremities - Gastrointestinal upset (nausea, abdominal pain) - Headache

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm in patients with reactive airway disease - Depression or mood changes - Allergic reactions (rash, angioedema) - Worsening heart failure in susceptible individuals

Before prescribing Metoprolol Retard Stada, clinicians should assess patient‑specific factors and monitor for potential complications. Cardiovascular assessment: evaluate baseline heart rate and blood pressure. Respiratory caution: avoid in patients with severe asthma or COPD without specialist advice. Diabetes monitoring: watch for masked hypoglycaemia symptoms. Concomitant drugs: review other rate‑controlling agents for additive effects. Gradual withdrawal: taper dose to prevent rebound hypertension or tachycardia. Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Metoprolol Retard Stada can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Verapamil or diltiazem: risk of severe bradycardia and AV block. - Clonidine abrupt discontinuation: may cause rebound hypertension. - Other antihypertensives (e.g., ACE inhibitors, diuretics): additive hypotensive effect. - Insulin or oral hypoglycaemic agents: may mask hypoglycaemia signs.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce antihypertensive response. - Diuretics: can enhance hypotensive effect, requiring dose adjustment.